{"created_at":"Mon Apr 14 16:08:43 +0000 2014","id":455739436957847552,"id_str":"455739436957847552","text":"RT @JohnCFierce: BREAKING: Novartis slams the brakes on RNAi development efforts $NVS - http:\/\/t.co\/o0jH86IXFM","source":"web","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":733717446,"id_str":"733717446","name":"Yu Zhu","screen_name":"YuZhu4","location":"","url":null,"description":null,"protected":false,"followers_count":20,"friends_count":92,"listed_count":0,"created_at":"Thu Aug 02 23:10:19 +0000 2012","favourites_count":3,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":636,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_0_normal.png","profile_image_url_https":"https:\/\/abs.twimg.com\/sticky\/default_profile_images\/default_profile_0_normal.png","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":true,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Apr 14 15:40:42 +0000 2014","id":455732384587988993,"id_str":"455732384587988993","text":"BREAKING: Novartis slams the brakes on RNAi development efforts $NVS - http:\/\/t.co\/o0jH86IXFM","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":102754598,"id_str":"102754598","name":"John Carroll","screen_name":"JohnCFierce","location":"Dorset, VT","url":"http:\/\/www.fiercebiotech.com","description":"John Carroll is the editor of FierceBiotech (11 years) and editor-in-chief of the life sciences group of pubs at Fierce. The thoughts expressed here are my own.","protected":false,"followers_count":13270,"friends_count":374,"listed_count":531,"created_at":"Thu Jan 07 18:33:18 +0000 2010","favourites_count":14,"utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":13645,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3772621461\/ee45dee41778a91205525a651bd06485_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3772621461\/ee45dee41778a91205525a651bd06485_normal.jpeg","profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":15,"favorite_count":5,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[64,68]}],"urls":[{"url":"http:\/\/t.co\/o0jH86IXFM","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/breaking-novartis-slams-brakes-rnai-development-efforts\/2014-04-14","display_url":"fiercebiotech.com\/story\/breaking\u2026","indices":[71,93]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[81,85]}],"urls":[{"url":"http:\/\/t.co\/o0jH86IXFM","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/breaking-novartis-slams-brakes-rnai-development-efforts\/2014-04-14","display_url":"fiercebiotech.com\/story\/breaking\u2026","indices":[88,110]}],"user_mentions":[{"screen_name":"JohnCFierce","name":"John Carroll","id":102754598,"id_str":"102754598","indices":[3,15]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
{"created_at":"Mon Apr 14 16:48:25 +0000 2014","id":455749427790372864,"id_str":"455749427790372864","text":"RT @JohnCFierce: BREAKING: Novartis slams the brakes on RNAi development efforts $NVS - http:\/\/t.co\/o0jH86IXFM","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":949195963,"id_str":"949195963","name":"Joe Prete, Pharm.D.","screen_name":"JoeP450","location":"Florida","url":null,"description":"Just a simple epicurean who traveled forward in time to present day with goal of not making money primarily in the biotech sector. Not financial advice.","protected":false,"followers_count":140,"friends_count":84,"listed_count":9,"created_at":"Thu Nov 15 06:44:01 +0000 2012","favourites_count":545,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":832,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3214723398\/24974873b236bc0409848b8948a6ab51_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3214723398\/24974873b236bc0409848b8948a6ab51_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/949195963\/1360132204","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Mon Apr 14 15:40:42 +0000 2014","id":455732384587988993,"id_str":"455732384587988993","text":"BREAKING: Novartis slams the brakes on RNAi development efforts $NVS - http:\/\/t.co\/o0jH86IXFM","source":"\u003ca href=\"https:\/\/about.twitter.com\/products\/tweetdeck\" rel=\"nofollow\"\u003eTweetDeck\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":102754598,"id_str":"102754598","name":"John Carroll","screen_name":"JohnCFierce","location":"Dorset, VT","url":"http:\/\/www.fiercebiotech.com","description":"John Carroll is the editor of FierceBiotech (11 years) and editor-in-chief of the life sciences group of pubs at Fierce. The thoughts expressed here are my own.","protected":false,"followers_count":13272,"friends_count":374,"listed_count":533,"created_at":"Thu Jan 07 18:33:18 +0000 2010","favourites_count":15,"utc_offset":-18000,"time_zone":"Central Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":13646,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"022330","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme15\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/3772621461\/ee45dee41778a91205525a651bd06485_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/3772621461\/ee45dee41778a91205525a651bd06485_normal.jpeg","profile_link_color":"0084B4","profile_sidebar_border_color":"A8C7F7","profile_sidebar_fill_color":"C0DFEC","profile_text_color":"333333","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":18,"favorite_count":6,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[64,68]}],"urls":[{"url":"http:\/\/t.co\/o0jH86IXFM","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/breaking-novartis-slams-brakes-rnai-development-efforts\/2014-04-14","display_url":"fiercebiotech.com\/story\/breaking\u2026","indices":[71,93]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"NVS","indices":[81,85]}],"urls":[{"url":"http:\/\/t.co\/o0jH86IXFM","expanded_url":"http:\/\/www.fiercebiotech.com\/story\/breaking-novartis-slams-brakes-rnai-development-efforts\/2014-04-14","display_url":"fiercebiotech.com\/story\/breaking\u2026","indices":[88,110]}],"user_mentions":[{"screen_name":"JohnCFierce","name":"John Carroll","id":102754598,"id_str":"102754598","indices":[3,15]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
